Revive Therapeutics
  • Home
  • About
    • Management Team
    • Advisory Clinical Team
    • Board of Directors
  • Pipeline
    • Infectious Diseases
    • Intellectual Property
  • Investor
  • News
  • Contact
Select Page

Revive Therapeutics Announces Upsize to Previously Announced Bought Deal Offering

by rvvadmin | Jan 21, 2021 | 2021

TORONTO, Jan. 21, 2021  – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE:RVV) (USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is...

Revive Therapeutics Announces $10 Million Bought Deal Offering of Units

by rvvadmin | Jan 20, 2021 | 2021

TORONTO, Jan. 20, 2021  – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV) (USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is...

Revive Therapeutics Announces Research Collaboration with North Carolina State University for Natural Biosynthesis Enzymatic Platform To Develop Psilocybin

by rvvadmin | Jan 14, 2021 | 2021

TORONTO, Jan. 14, 2021 – Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce it has...
Next Entries »

NEWS

2022

2021

2020

2019

Click Here for more news.
(Forwards to SEDAR website)

Privacy Policy

Disclaimer

  • Facebook
  • X
  • Instagram
© COPYRIGHT 2025. Revive Therapeutics Ltd. ALL RIGHTS RESERVED.